NCT00245154 Paclitaxel + Carboplatin With/Out Cediranib Maleate in Stage III or Stage IV Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2/PHASE3
NCT00243867 Taxoprexin Plus Carboplatin Treatment for Advanced Lung Cancer Status COMPLETED Phase PHASE3
NCT00238615 Phase II Docetaxel / Carboplatin / XRT + Surgical Resection in Stage III NSCLC Status TERMINATED Phase PHASE2
NCT00238173 Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors Status TERMINATED Phase PHASE1
NCT00238147 Combination Chemotherapy and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Locally Advanced Esophageal Cancer Status COMPLETED Phase PHASE1
NCT00234052 Carboplatin, Pemetrexed Disodium, and Bevacizumab in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00232505 Cetuximab + / - Carboplatin for Estrogen Receptor-Negative, Progesterone Receptor-Negative Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT00231582 High-dose Chemotherapy With Autologous Stem Cell Transplantation in Poor Prognosis Germ-cell Tumors: TAXIF II Status COMPLETED Phase PHASE2
NCT00230542 Carboplatin and Pemetrexed in Recurrent Platinum Sensitive Ovarian Cancer Status COMPLETED Phase PHASE2
NCT00228319 Treatment of Newly Diagnosed Ovarian Cancer With Antioxidants Status COMPLETED Phase PHASE1/PHASE2
NCT00227565 Pemetrexed Disodium and Carboplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00226590 Induction Gemcitabine & Carboplatin Followed by Paclitaxel & Carboplatin +XRT in NSCLC Status COMPLETED Phase PHASE2
NCT00217568 Docetaxel and Carboplatin in Treating Patients With Relapsed Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal Cavity Cancer Status COMPLETED Phase PHASE2
NCT00217529 Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00215930 The 'MADe IT' Clinical Trial: Molecular Analyses Directed Individualized Therapy for Advanced Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00214058 Weekly Carboplatin/Docetaxel for Recurrent Ovarian/Peritoneal Cancer Status COMPLETED Phase PHASE2
NCT00204646 Neoadjuvant Adriamycin and Ifosfamide Plus High-Dose ICE in Patients With Soft Tissue Sarcoma (STS) Status COMPLETED Phase PHASE2
NCT00201734 Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown Primary Status TERMINATED Phase PHASE1/PHASE2
NCT00193895 Post-operative Concurrent Chemo-radiotherapy Versus Post-operative Radiotherapy for Cancer of the Head and Neck Status COMPLETED Phase PHASE3
NCT00193596 Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site Status COMPLETED Phase PHASE3